On Demand Webinars – SARS-CoV-2 genome sequencing, metatranscriptomics and host gene expression, immune response and pathway studies

qiagen

Explore how our high-performance NGS solutions can advance coronavirus research

Uncovering the multiple facets of SARS-CoV-2 biology can trigger advances in vaccine and drug discovery research. Examining virus phylogenetics and evolution, as well as investigating virus-host-microbiome interactions and host immune and pathway responses can instigate deeper, more holistic insights into SARS-CoV-2 biology. Join our webinar series on coronavirus research applications, from molecular epidemiology and metatranscriptomics to immune response and pathway research. Part 1 introduces our new NGS panel for targeted sequencing of the complete SARS-CoV-2 genome. Find out how this time-saving workflow allows you to multiplex up to 384 samples and rapidly analyze your data with integrated and optimized analysis pipelines. Part 2 investigates the importance of rRNA removal for RNA-seq applications involving viruses, host responses and metatranscriptomics, and part 3 discusses how targeted RNA panels are used for SARS-CoV-2 identification and host gene expression.

Register now to discover how the full spectrum of our innovative NGS solutions and integrated bioinformatics tools can further your coronavirus research.

  • Title: Using targeted whole viral genome sequencing to understand COVID-19
  • Date: Wednesday, June 17, 2020
  • Time: 9:00 a.m. and 1:00 p.m. EDT
  • Speaker: Brian Dugan, M.S., Associate Director, Global Product Management, Genomics, QIAGEN
WATCH NOW
  • Title: The importance of rRNA removal for RNA-seq applications involving viruses, host responses and metatranscriptomics
  • Date: Wednesday, June 24, 2020
  • Time: 9:00 a.m. and 1:00 p.m. EDT
  • Speaker: Samuel Rulli, Ph.D., Associate Director, RNA-seq profiling, NGS assay technologies, QIAGEN
WATCH NOW
  • Title: Gene expression from low-input and low-quality RNA samples – using targeted RNA panels for SARS-CoV-2 identification and host gene expression studies
  • Date: Tuesday, June 30, 2020
  • Time: 9:00 a.m. and 1:00 p.m. EDT
  • Speaker: Samuel Rulli, Ph.D., Associate Director, RNA-seq profiling, NGS assay technologies, QIAGEN
WATCH NOW

Leave a Reply

Your email address will not be published. Required fields are marked *

*

Time limit is exhausted. Please reload CAPTCHA.